Home > Share Market > Stocks > Strides pharma science > Financial Statements > STAR Key Financial Ratios

Strides pharma science Financial Statements

Strides pharma science Key Financial Ratios

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth 20.50 (3.10) 3.05 (3.70)
Op profit growth 23.10 30.10 (25) 27.40
EBIT growth 21.40 17.50 (40) 50
Net profit growth 638 (94) 65.20 268
Profitability ratios (%)        
OPM 19.10 18.70 14 19.10
EBIT margin 14.50 14.40 11.90 20.40
Net profit margin 8.10 1.32 23.30 14.50
RoCE 9.54 7.42 5.41 8.66
RoNW 2.53 0.36 6.34 3.70
RoA 1.33 0.17 2.65 1.54
Per share ratios ()        
EPS 28.70 3.42 76.50 49.90
Dividend per share 2.50 14 2 4.50
Cash EPS 6.93 (15) 56.60 30.60
Book value per share 310 282 275 307
Valuation ratios        
P/E 29.40 94.30 8.51 21.30
P/CEPS 122 (21) 11.50 34.70
P/B 2.73 1.14 2.36 3.45
EV/EBIDTA 14.20 8.59 16.80 19.10
Payout (%)        
Dividend payout -- -- 2.71 10.10
Tax payout (9.60) (4.70) (6.90) (17)
Liquidity ratios        
Debtor days 112 120 121 134
Inventory days 109 88.50 82.60 89.10
Creditor days (138) (125) (112) (128)
Leverage ratios        
Interest coverage (3.20) (2.50) (1.70) (3.10)
Net debt / equity 0.78 0.79 0.90 1.23
Net debt / op. profit 3.42 3.87 5.59 6.39
Cost breakup ()        
Material costs (40) (41) (49) (46)
Employee costs (17) (16) (15) (15)
Other costs (24) (24) (22) (19)

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000